Systemic
treoxin

treoxin

Complete respiratory treatment with just a single administration

The modernization of industrial swine production has substantially improved farm performance indicators. However, increased animal density, associated with other risk factors, exposes pigs to numerous respiratory diseases, which are currently the leading cause of the greatest health-related economic losses.

With this in mind, Farmabase launches TREOXIN, 10% tulathromycin, the most effective molecule for the treatment of the main respiratory pathogens affecting pigs, now accessible and viable for swine production.

• Latest-generation semi-synthetic macrolide;
• High concentration in immune cells;
• High affinity for lung tissue;
• Proven efficacy;
• Prolonged therapeutic effect;
• Farmabase quality.

FORMULA:
Each 100 mL of TREOXIN contains:
Tulathromycin …………………………………………….. 10 g
Excipient q.s. to …………………………………….. 100 mL

INDICATIONS:

TREOXIN is indicated for the treatment of respiratory diseases in swine and cattle. Susceptible etiological agents include:

In Swine: Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Haemophilus parasuis, Mycoplasma hyopneumoniae, and Pasteurella multocida.

In Cattle: Fusobacterium necrophorum, Pasteurella multocida, Dichelobacter nodosus, Mannheimia haemolytica, Histophilus somni, and Moraxella bovis.

DIRECTIONS FOR USE:

Presentation

Presentation

Bottles containing 50 and 100 mL.

Withdrawal Period

OBSERVE THE FOLLOWING WITHDRAWAL PERIOD:

PIGS:
Treated pigs may only be slaughtered 16 DAYS after the last administration.

CATTLE:
Treated cattle may only be slaughtered 79 DAYS after the last administration.

Compartilhar:

OTHER PRODUCTS FROM Sistêmicos: